Intercept Can't Dodge Investors' Stock Drop MDL
A New York federal judge on Wednesday refused to dismiss multidistrict litigation brought by investors accusing Intercept Pharmaceuticals Inc. of securities fraud, finding the investors provided evidence that the company and...To view the full article, register now.
Already a subscriber? Click here to view full article